Serielle_ESR1-Testung_beim_fortgeschrittenen_ER-positiven,_HER2-negativen_Mammakarzinom.nub
NUB-Anfragen 2027
Serielle_ESR1-Testung_beim_fortgeschrittenen_ER-positiven,_HER2-negativen_Mammakarzinom.nub
27-173 Denecimig NUB-Anfrage DGHO Stand 2026-10-05 final.pdf
Denecimig.nub
27-172 Pimicotinib NUB-Anfrage DGHO Stand 2026-10-05 final.pdf
Pimicotinib.nub
27-011 Aumolertinib NUB-Anfrage DGHO Stand 2026-10-05 final.pdf
Aumolertinib.nub
27-166 Nogapendekin alfa inbakicept NUB-Anfrage DGHO Stand 2026-10-05 final.pdf
Nogapendekin_alfa_inbakicept.nub
27-167 Sonrotoclax NUB-Anfrage DGHO Stand 2026-10-05 final.pdf
Sonrotoclax.nub
27-056 Etranacogen dezaparvovec NUB-Anfrage DGHO Stand 2026-10-06 final.pdf
Etranacogen_dezaparvovec.nub
27-182 Rilzabrutinib NUB-Anfrage DGHO Stand 2026-10-06 final.pdf
Rilzabrutinib_.nub
27-180 Cosibelimab NUB-Anfrage DGHO Stand 2026-10-01 final.pdf
Cosibelimab.nub
27-178 Ensartinib NUB-Anfrage DGHO Stand 2026-10-08 final.pdf
Ensartinib.nub
27-177 Relacorilant NUB-Anfrage DGHO Stand 2026-10-15 final.pdf